Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 28 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Health-related quality of life is impaired with IBD

Ulcerative colitis and Crohn's disease impair patients' health-related quality of life and the degree of impairment depends on disease activity, finds May's issue of the Inflammatory Bowel Disease.

News image

fiogf49gjkf04

Inflammatory bowel disease (IBD) impairs patients' perception of health and has a negative impact on health-related quality of life.

Most studies include patients from a single hospital, which may bias results through the use of small patient samples and/or samples within a restricted disease spectrum.

Dr Casellas and colleagues measured health-related quality of life in patients with ulcerative colitis and Crohn's disease from 9 hospitals located in different geographical areas in Spain.

The researchers used 2 questionnaires including the Spanish version of the Inflammatory Bowel Disease Questionnaire and the EuroQol, expressing the results as medians.

The research team included 1156 patients, of which 528 had ulcerative colitis and 628 had Crohn’s disease.

The patients’ median age was 35 years with a slight predominance of women patients at 617 versus 539 male patients.

All 5 dimensions of the IBD questionnaire showed lower scores with active ulcerative colitis
Inflammatory Bowel Disease

The researchers found that health-related quality of life worsened in parallel with disease severity to a similar extent in both ulcerative colitis and Crohn’s.

Inflammatory Bowel Disease Questionnaire scores for ulcerative colitis were 6, 5, and 4 for the 3 disease severity groups, respectively.

The team noted that Inflammatory Bowel Disease Questionnaire scores for Crohn’s disease were 6, 5, and 4, respectively.

The investigators observed a similar inverse relation between clinical activity and quality of life when EuroQol preference values were used.

The team found that all 5 dimensions of the Inflammatory Bowel Disease Questionnaire showed significantly lower scores in patients with active ulcerative colitis and Crohn’s disease than in patients in remission.

The pattern of scores by Inflammatory Bowel Disease Questionnaire dimensions differed between patients in relapse, who scored worse on the digestive symptoms dimension, and patients in remission.

In addition, the researchers found that disease activity, time of evolution since diagnosis and female sex, were significantly associated with having a worse perception of health-related quality of life.

The team reported that the type of disease or geographical area of residence did not influence results on the Inflammatory Bowel Disease Questionnaire.

Dr Casellas concludes, “Ulcerative colitis and Crohn’s disease impair patients' health-related quality of life.”

“The degree of impairment depends on disease activity but is independent of the type of disease and place of residence.”

Inflamm Bowel Dis 2005: 11(5): 488
04 May 2005

Go to top of page Email this page Email this page to a colleague

 28 May 2018 
Therapeutic strategies for HCV
 28 May 2018 
Mesalazine in ulcerative colitis
 28 May 2018 
Technology and management of digestive diseases
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us